{
    "meeting_annotations": [
        {
            "speaker": "Melanie Gareau",
            "timestamp": "00:03-00:49",
            "transcript": "So if I can go back to the metabolites, I know that we we use using chambers to study intestinal physiology, so we can look at ion transport and permeability in pretty good detail. And if you provide short chain fatty acids for example, you can improve or disrupted barriers. So metabolites can play a role. Um with respect to the correlation versus association, the best one that I know of is IBD where you can measure permeability defects in patients before they become IBD patients if you'll do a screen. So it suggests that permeability is one of the initiating factors, whether that's caused by microbiome changes is unknown at the time right now, but certainly genetic susceptibility is correlated with that. So now we're trying to put together genetics, permeability, microbiome and that I don't think that's still resolved right yet, but",
            "speaking duration": 46.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Melanie Gareau",
            "timestamp": "00:49-01:14",
            "transcript": "the other thing that we haven't mentioned is um whether things get in through permeability and then a second hit like stress is the one that breaks the central barrier for example because we know that stress can impact the endothelial barrier in the brain and and modulate blood brain barrier function. So um I think there's still a lot of black boxes in all this, but um certainly you can sometimes decouple those two.",
            "speaking duration": 25.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Rosa Krajmalnik-Brown",
            "timestamp": "01:16-01:17",
            "transcript": "What do you think, Tom?",
            "speaking duration": 1.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Tom Mansell",
            "timestamp": "01:20-02:10",
            "transcript": "So I'm I'm a bacteria person and the host aspect is is is not my area of expertise, but I do know that there are probiotics that if you when administered, they do create better tight junctions, right? So E coli Nissle is an example um of uh a probiotic that um one of its functions of course is to is is niche defense because it's very similar to Shigella and uh Salmonella, but um uh another thing that that's been found is in in these kind of monolayer type studies, right? Not I don't know about in vivo right now, but um you you find increased tight junction formation just from the administration of this this E coli Nissle. Um and so the",
            "speaking duration": 50.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Tom Mansell",
            "timestamp": "02:10-03:11",
            "transcript": "mechanism of that is not not yet known, but I think in in general, what what I would like to understand is um what is the host? So there's, you know, we monitor these things with what E cadherin uh and and other gene expression, right? So um but the actual barrier between cells is uh a sort of mostly protein, mostly extracellular matrix type material, like what is the downstream effect? Like what what we're talking about so far is like what signaling leads to this phenotype, right? But is it is there something about like um the the protein or carbohydrate makeup or availability of those things that may um that may contribute to that and you know, that's that's just I I think about things a lot of molecular level. So that's that's kind of where I'm sort of coming from here and so if anybody can enlighten me in that respect, that would be great.",
            "speaking duration": 61.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Faranak Fattahi",
            "timestamp": "03:11-03:26",
            "transcript": "Are you thinking that some of those components could be affected by the microbiome as well? Like it could be directly secreted by them or expressing those proteins in the host could be altered by factors from the microbiome?",
            "speaking duration": 15.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Tom Mansell",
            "timestamp": "03:27-03:36",
            "transcript": "Right, so that could be a possible explanation for why short chain fatty acids would do that for example, right? Um as histone deacetylase inhibitors.",
            "speaking duration": 9.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Tom Mansell",
            "timestamp": "03:36-03:41",
            "transcript": "Um but yeah, I'm I'm really thinking more about the physical makeup of the barrier.",
            "speaking duration": 5.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Erin Longbrake",
            "timestamp": "03:41-03:42",
            "transcript": "Yeah.",
            "speaking duration": 1.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Rosa Krajmalnik-Brown",
            "timestamp": "03:42-03:42",
            "transcript": "there.",
            "speaking duration": 0.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Tom Mansell",
            "timestamp": "03:42-03:49",
            "transcript": "I wonder if there are particular I wonder if there are particular for example limiting limiting carbohydrates or limiting amino acids, right? If it's all collagen or you know,",
            "speaking duration": 7.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Tom Mansell",
            "timestamp": "03:49-03:50",
            "transcript": "arginine.",
            "speaking duration": 1.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Iliyan Iliev",
            "timestamp": "03:50-03:50",
            "transcript": "Yeah.",
            "speaking duration": 0.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Tom Mansell",
            "timestamp": "03:50-03:50",
            "transcript": "I understand like that, you know,",
            "speaking duration": 0.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Tom Mansell",
            "timestamp": "03:50-03:50",
            "transcript": "Um",
            "speaking duration": 0.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Tom Mansell",
            "timestamp": "03:50-03:50",
            "transcript": "is that something that that we can that we can map back by by metabolomics?",
            "speaking duration": 0.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Iliyan Iliev",
            "timestamp": "04:58-05:03",
            "transcript": "And it's probably worth also thinking that sorry, where are you? Erin, where are you?",
            "speaking duration": 5.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Erin Longbrake",
            "timestamp": "05:03-05:14",
            "transcript": "Yeah, I was just going to say that something that seems like could be a question that could be studied in an in vitro model system.",
            "speaking duration": 11.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Erin Longbrake",
            "timestamp": "05:14-05:14",
            "transcript": "I don't know the answer though, but it seems like a question that would be amenable to in vitro studies.",
            "speaking duration": 0.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Rosa Krajmalnik-Brown",
            "timestamp": "05:14-05:21",
            "transcript": "Sorry, the internet kicked me out and it took me a while to be able to get back in. So I hope you guys were doing great without your moderator.",
            "speaking duration": 7.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Tom Mansell",
            "timestamp": "05:22-05:24",
            "transcript": "Just me talking, so no.",
            "speaking duration": 2.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Faranak Fattahi",
            "timestamp": "05:24-05:25",
            "transcript": "Yeah.",
            "speaking duration": 1.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Iliyan Iliev",
            "timestamp": "05:26-06:08",
            "transcript": "Dave, I think you were going to say something there. Sorry. Oh, I was just going to bring up a more direct interaction not necessarily metabolites, but active things like proteases like ginger panes and things that can uh at least from the oral bacteria uh have been shown to both break down the epithelium as well as the endothelial barrier uh in brain. Um so that's more of a a direct protease route which has been shown to have effects at both sites.",
            "speaking duration": 42.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Rosa Krajmalnik-Brown",
            "timestamp": "06:09-06:17",
            "transcript": "Yeah. So in the gut um um Iliyan, I don't know if you looked at proteases and fungi because that might be important also.",
            "speaking duration": 8.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Iliyan Iliev",
            "timestamp": "06:17-07:15",
            "transcript": "Yeah, we do. We do. We actually have few candidates that that we discovered with uh yeah, human uh human uh antibody assays. Uh and they they are few proteases that are uh you know, that are involved but uh I'm not sure at what level because there are two ways how the barrier, at least two ways, right? How the barrier might be impaired. It can be directly through, you know, tight junction defects and then uh you know, external factors that are uh that are basically aggravating those phenotypes. But then the other problem is actually reparative problems. So those are like very long term uh you know,",
            "speaking duration": 58.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Iliyan Iliev",
            "timestamp": "07:15-08:05",
            "transcript": "you know, processes and they can be taking part in specific areas of the intestine. So it's different from the cellular and both of those have similar effect of increased permeability. So so so that's how it's very complicated, right? There there is so much uh to do on that side, but uh but you know, those two different levels of complication a bit mess up uh the screening approaches because if you start looking at tight junctions, you can set up an in vitro platform and do some part of that with the caveat you don't have immune system then, which is very important for this process of basically bringing up the tight junctions.",
            "speaking duration": 50.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Erin Longbrake",
            "timestamp": "08:05-08:55",
            "transcript": "That's a good point though. Um so it sounds and going back to the original question, it sounds plausible that certain microbes um either make small metabolites that impact the barrier or make proteases that impact components of the barrier. But certainly immune cells also impact immune cells which are in the mucosal layers and certainly immune cells have a number of ways to bypass barriers um to migrate into both the brain and other parts of the body to make active metabolites and so you know that one question could be whether the it's a direct effect of um microbes and microbial products or whether the immune cells serve as a as a mediator.",
            "speaking duration": 50.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Iliyan Iliev",
            "timestamp": "08:56-09:00",
            "transcript": "And there is one more component actually, toxins.",
            "speaking duration": 4.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Iliyan Iliev",
            "timestamp": "09:00-09:22",
            "transcript": "So we just had a study uh there is a fungal toxin that is basically directly uh uh lytic to epithelial cells and microphages underneath.",
            "speaking duration": 22.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Iliyan Iliev",
            "timestamp": "09:22-09:30",
            "transcript": "And so that is messing up the system a lot and that's not a protease.",
            "speaking duration": 8.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Iliyan Iliev",
            "timestamp": "09:30-09:30",
            "transcript": "Uh",
            "speaking duration": 0.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Iliyan Iliev",
            "timestamp": "09:30-10:00",
            "transcript": "So so so that was something very surprising. So those also can play a role depends on the concentrations and where they're released. And so how did you how did you find these toxins? Because you were doing promics and you found this instead of a protease?",
            "speaking duration": 30.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        },
        {
            "speaker": "Iliyan Iliev",
            "timestamp": "10:00-10:15",
            "transcript": "No, it's a huge study. So we started differently. So we first looked at uh patients with IBD where we were looking for specific fungi. So we found actually fungi that are enriched in those specific patients and from there we wanted to see uh if there is any correlation with uh enrichment of those fungi and the disease.",
            "speaking duration": 15.0,
            "interuption": "No",
            "screenshare": "No",
            "screenshare_content": "None",
            "other": "None"
        }
    ]
}